Incorporated in 2018 in Nanjing, Singleron has a world-leading one-stop single cell sequencing products platform, providing all round solutions from sample transport to data analysis and interpretation, and annotating single cell sequencing data to exploit clinical value. The platform includes uniquely designed microfluidic single cell processing device Singleron Matrix™, and the GEXSCOPE® single cell system based on this microfluidic device as well as SynEcoSys™single cell database. The GEXSCOPE® system offers a single cell analysis product format that is highly suitable for clinical applications by addressing typical challenges in single cell sequencing workflow.
Singleron has attracted a team of experts with diverse expertise since its incorporation. Currently, there are over 240 full-time employees in the company. The leadership team and key employees have long-year industry experience in multinational companies. Many of them have been selected into the Talent Attractions Program of Nanjing/Suzhou/Jiangsu.